HUTCHMED (China) (HMDCF) Cash from Investing Activities (2018 - 2021)

HUTCHMED (China) (HMDCF) reported Cash from Investing Activities of -$315.9 million for Q2 2021, down 665.3% year-over-year from $55.9 million in Q2 2020, and down 297.41% quarter-over-quarter from $160.0 million in Q1 2021.

HUTCHMED (China) (HMDCF) Cash from Investing Activities (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has 4 years of Cash from Investing Activities data on file, last reported at -$315.9 million in Q2 2021.

  • Cash from Investing Activities for Q2 2021 came in at -$315.9 million, down 665.3% year-over-year; the trailing twelve-month figure through Jun 2021 was -$295.0 million (down 281.98% YoY), and the FY2025 annual result was -$29.4 million, up 69.38% from the prior year.
  • Cash from Investing Activities slipped to -$315.9 million in Q2 2021 per HMDCF's latest filing, from $160.0 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $160.0 million in Q1 2021 and troughed at -$315.9 million in Q2 2021.
  • A 4-year average of -$11.0 million and a median of $19.0 million in 2019 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2019 and 2021: Cash from Investing Activities surged 299.29% in 2019, then tumbled 665.3% in 2021.
  • A 4-year view of Cash from Investing Activities shows it stood at -$15.3 million in 2018, then soared by 193.2% to $14.2 million in 2019, then sank by 390.3% to -$41.3 million in 2020, then plunged by 665.3% to -$315.9 million in 2021.
  • Business Quant data shows HMDCF's Cash from Investing Activities at -$315.9 million in Q2 2021, $160.0 million in Q1 2021, and -$41.3 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 HUTCHMED (China) - - - -

Historic Data

Download Data
DateValue
Jun 30, 2021 -315.92 Mn
Jun 30, 2021 -315.92 Mn
Mar 31, 2021 160.04 Mn
Mar 31, 2021 160.04 Mn
Jun 30, 2020 -41.28 Mn
Jun 30, 2020 -41.28 Mn
Mar 31, 2020 -97.84 Mn
Mar 31, 2020 -97.84 Mn
Dec 31, 2019 14.22 Mn
Dec 31, 2019 14.22 Mn
Sep 30, 2019 47.67 Mn
Sep 30, 2019 47.67 Mn
Jun 30, 2019 23.76 Mn
Jun 30, 2019 23.76 Mn
Mar 31, 2019 33.38 Mn
Mar 31, 2019 33.38 Mn
Dec 31, 2018 -15.26 Mn
Dec 31, 2018 -15.26 Mn
Sep 30, 2018 43.22 Mn
Sep 30, 2018 43.22 Mn